JAMA Dermatology’s mission is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, to enable dermatologists …JAMA Dermatology’s mission is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, to enable dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care. The journal publishes a broad range of innovative studies and trials that shift research and ... JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Disclaimer: Dr Barbieri is the CME/Clinical Review and Education Editor of JAMA Dermatology but was not involved in any of the decisions regarding review of the manuscript or its acceptance. References 1. Lainscak M , Pelliccia F , Rosano G , et al. Safety profile of mineralocorticoid receptor antagonists: spironolactone and eplerenone. …The VU Journal Publishing Guide shows you the most important scientific journals in your field, with their impact metrics, Open Access possibilities and APC ...JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' …Key Points. Question Are oral nutraceuticals a safe and effective treatment for patients with acne?. Findings In this systematic review of 3346 participants in 42 unique studies, 4 good-quality studies of nutraceuticals demonstrated effectiveness of vitamin D, green tea extract, probiotics, and cheongsangbangpoong-tang in the treatment of acne. Several other fair …Before dermatology evaluation, he was treated for presumed facial impetigo with mupirocin, 2%, ointment and condyloma with imiquimod, 5%, cream. Examination demonstrated 2 umbilicated and ulcerated, skin-colored papules on the genitals, as well as a honey-colored crusted papule on the face ( Figure ).The most common dermatologic treatment during a flare episode was topical corticosteroids (35% of flare episodes [178 of 513]) followed by other oral dermatologic treatments (eg, methotrexate, cyclosporine, tacrolimus; 13% [67 of 513]), and oral corticosteroids (11% [54 of 513]) . Opioids were prescribed during 21% of flare episodes …Disclaimer: Dr Barbieri is the CME/Clinical Review and Education Editor of JAMA Dermatology but was not involved in any of the decisions regarding review of the manuscript or its acceptance. References 1. Lainscak M , Pelliccia F , Rosano G , et al. Safety profile of mineralocorticoid receptor antagonists: spironolactone and eplerenone. …2023;159 (3):247-248. doi:10.1001/jamadermatol.2022.6162. Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis. Atopic dermatitis (AD) is a …Clean beauty, also known as natural skin care, is having a moment. From 2017 to 2018, the natural skin care market grew by 23% to 1.6 billion dollars, accounting for over 25% of the 5.6 billion dollars of annual skin care sales in 2018.1 Staunch warnings from influencers such as Gwyneth Paltrow,... JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …JAMA Dermatology Hair loss (alopecia) is categorized as scarring (with permanent destruction of hair follicles) or nonscarring. Nonscarring alopecia is the most common form of hair loss and can be classified as patterned, diffuse, or focal, based on the distribution of hair loss.JAMA Dermatology Patient Page. Measles. Bharath Balu, PhD; Eliot N. Mostow, MD, MPH. JAMA Dermatology. Measles (rubeola) is an infection caused by a highly contagious virus primarily spread by respiratory droplets. How Common Is Measles and How Contagious Is It? Measles is currently rare in the US because highly effective vaccines …Importance Pubic hair grooming is an increasingly prevalent trend. Several studies have sought to characterize its prevalence, associated demographics, and motivations. Objective To characterize current pubic hair grooming practices in the United States.. Design, Setting, and Participants In this cross-sectional study, a nationally representative survey was …JAMA Dermatology. Key Points. Question What is the efficacy and safety of targeted interleukin-13 treatment with tralokinumab monotherapy in adolescents with moderate to severe atopic dermatitis? Findings In this randomized clinical trial of 289 patients aged 12 to 17 years, a statistically significant higher number of patients treated with tralokinumab vs …Oct 2, 2019 · Key Points. Question What is the efficacy and safety of abrocitinib monotherapy in patients with moderate-to-severe atopic dermatitis?. Findings In this randomized clinical trial of 391 patients 12 years or older with moderate-to-severe atopic dermatitis, significantly greater proportions of patients treated with abrocitinib (200 mg or 100 mg) compared with placebo achieved an Investigator ... JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Traditional Chinese Medicine (TCM) aims to promote health by bringing the body’s systems into balance. Learn how this ancient approach can be a helpful part of eczema management. P...Archives of Dermatology Reader's Choice: Continuing Medical Education · Citation · We recommend · JAMA Dermatology · JAMA Network · Help.Chronic pruritus is a debilitating symptom that is associated with numerous dermatologic, neurologic, and systemic diseases. It is often resistant to treatment and can cause a severe reduction in quality of life. 1 Currently, to our knowledge, there is a lack of US Food and Drug Administration–approved therapies for pruritus, so treatment can be difficult and relies on …Importance Knowledge regarding differences in dermatologic care for patients with a broad range of dermatologic conditions is limited.. Objective To elucidate nationwide differences in use of outpatient dermatologic care.. Design, Setting, and Participants Retrospective analysis of nationally representative data from the 2007 to 2015 Medical Expenditure …Feb 14, 2024 · Systemic Immunomodulatory Treatments for Atopic Dermatitis. Explore the latest treatments for vitiligo, hidradenitis suppurativa, lichen sclerosus, melanoma, …Archives of Dermatology Reader's Choice: Continuing Medical Education · Citation · We recommend · JAMA Dermatology · JAMA Network · Help.JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA …JAMA Dermatology. Key Points. Question What is the diagnostic accuracy of clinical examination and baseline ultrasonography for the detection of regional lymph node metastasis in patients with high-risk cutaneous squamous cell carcinoma (SCC) of the head and neck, and what is the diagnostic accuracy of ultrasonography among patients with …JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Dermatology. Key Points. Questions What is the drug survival of adalimumab, ustekinumab, secukinumab, guselkumab, ixekizumab that is associated with effectiveness and safety in patients with psoriasis in the UK and Ireland, and are there any patient factors that are associated with survival of each biologic differently that could help treatment …[email protected] Hours: 8:30 AM to 4:45 PM CT Monday through Friday USA & Canada: +1 800.262.2350 Rest of World: +1 312.670.7827. Phone: 1-312-464-4444 Hours: 7:00 AM to 5:00 PM CT Monday through Friday. Instructions for Authors and Information on Submitting Manuscripts. [email protected] JAMA Network Open …23 Mar 2022 ... JAMA Dermatology—The Year in Review, 2021 ... In the face of uncertainty and an ever-evolving global pandemic, JAMA Dermatology continued to ...Wollenberg A , Barbarot S , Bieber T , et al; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and ... Evidence Review A panel of national experts in pediatric dermatology, procedural/cosmetic dermatology, plastic surgery, scars, wound healing, acne, and isotretinoin was convened. A systematic PubMed review of English-language articles published from 1982 to 2017 was performed using the following search terms: isotretinoin, 13-cis-retinoic acid ... JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Explore health information written for patients from JAMA Dermatology’s editors, including easy-to-understand explanations of atopic dermatitis, psoriasis, and more. Add to My …Aug 14, 2021 · a For patients with worst pruritus NRS greater than 1 at baseline.. b Data from Measure Up 1 and Measure Up 2 studies. 10. EASI 90/100 indicates 90% or greater/100% improvement in Eczema Area and Severity Index; ITT, intention to treat for the main study; NRS, numeric rating scale; OC, observed case; PBO, placebo; UPA, upadacitinib; vIGA-AD 0, Validated Investigator Global Assessment for ... Dec 1, 2013 · Goldsmith LA, Bolognia JL, Callen JP, et al; American Academy of Dermatology. American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations [published correction appears in J Am Acad Dermatol . 2004:51(3):348]. JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Importance Dupilumab is a theoretically novel therapy for bullous pemphigoid (BP). However, its effectiveness and safety have yet to be confirmed in a large-scale study. Objective To assess the efficacy and safety of dupilumab in patients with BP and evaluate factors that potentially affect short-term and long-term outcomes.. Design, Setting, and …JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) 1 May 2022 ... JAMA Dermatology · 7,088 Views. Vulvar Lichen Sclerosus · 4,439 Views. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040.Aug 1, 2020 · Confirmation of the association between diet and acne is sought out by many, and with conflicting studies, it becomes murky. Several confounding factors have been controlled for and it appears the participants go through somewhat extensive questionnaires, with the number of uncompensated steps required in participation in this study, what is the impact, if any, of self-selection bias on the study. JAMA Dermatology. Key Points. Question What is the short-term and long-term comparative efficacy among biologics and oral agents for plaque psoriasis? Findings In a network meta-analysis of 60 clinical …Hidradenitis suppurativa (HS) is relatively common, with the prevalence of 0.05% to 4.10%, yet many patients receive inadequate treatment. To review the diagnosis, epidemiology, and treatment of HS with an emphasis on advances in the last 5 years. A literature search was conducted using PubMed, MEDLINE (Medical Subject Headings …JAMA Dermatology. Key Points. Question What are the clinicopathologic features of persistent chemotherapy-induced alopecia (pCIA) in breast cancer survivors? Findings Most patients in this case series presented with either diffuse alopecia or hair thinning in the distribution of female pattern hair loss, with trichoscopic and histopathologic features …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …JAMA Dermatology. Key Points. Question What are the long-term clearance rates of treatments used in patients with actinic keratosis? Findings This systematic review and network meta-analysis included data from 15 randomized clinical trials reporting sustained clearance rates after at least 12 months of treatment as a proxy for long-term efficacy. …Eleven women presented with chronic severe pain and/or pruritus of the scalp only without objective physical findings, a condition we term "scalp dysesthesia." Five women described pain, stinging, or burning only; 4 women complained of pain and pruritus; and 2 women reported pruritus only. The patients ranged in age from 36 to 70 years. The most common dermatologic treatment during a flare episode was topical corticosteroids (35% of flare episodes [178 of 513]) followed by other oral dermatologic treatments (eg, methotrexate, cyclosporine, tacrolimus; 13% [67 of 513]), and oral corticosteroids (11% [54 of 513]) . Opioids were prescribed during 21% of flare episodes …18 Apr 2018 ... Based on these findings, the study suggests that the “diagnostic accuracy of PAs may be lower than that of dermatologists.” However, the study ...JAMA Dermatology’s mission is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, to enable dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care. The journal publishes a broad range of innovative studies and trials that shift research and ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Key Points. Question Are oral nutraceuticals a safe and effective treatment for patients with acne?. Findings In this systematic review of 3346 participants in 42 unique studies, 4 good-quality studies of nutraceuticals demonstrated effectiveness of vitamin D, green tea extract, probiotics, and cheongsangbangpoong-tang in the treatment of acne. Several other fair …Key Points. Question What is the efficacy and safety of once-daily roflumilast foam, 0.3%, in adult patients with seborrheic dermatitis?. Findings In this randomized clinical trial that included 226 patients with seborrheic dermatitis, 73.8% of roflumilast-treated patients achieved Investigator Global Assessment success at week 8 compared with 40.9% in the vehicle group, a statistically ... JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …20 May 2016 ... Review in JAMA Dermatology journal See cases that were sent in https://t.co/LQTW8t8iTS…/ https://t.co/iTNrlbuzm3.In individual patients, the risks and benefits of WW and treatment can be weighed using this algorithm. The frequency of follow-up visits (eg, every 3-6 months) should be based on the feasibility for individual cases and can be adjusted (preferably by visiting a dermatology outpatient clinic when feasible; if not possible, eg, follow-up through teledermatology or general practitioner) when ... JAMA Dermatology. Key Points. Question Is patient age associated with rate of lymph node positivity in clinically localized thin melanoma? Findings In this cohort study of a national data set of 8772 patients undergoing curative resection of thin melanoma, older age was significantly associated with reduced risk of lymph node metastases. Patients …Importance Determining psoriasis prevalence is fundamental to understanding the burden of the disease, the populations most affected, and health policies to address the disease.. Objective (1) To determine the prevalence of psoriasis among adults in the US and (2) to evaluate the change in psoriasis prevalence over time since the 2003-2004 National …JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) 1 Division of Dermatology, Department of Internal Medicine, Dell Medical School, The University of Texas at Austin. 2 LIVESTRONG Cancer Institutes, Dell Medical School, ... JAMA Dermatology. PMID: 33325988 DOI: 10.1001/jamadermatol.2020.4616 Abstract Importance: While current evidence supports UV exposure as an important risk …18 Apr 2018 ... Based on these findings, the study suggests that the “diagnostic accuracy of PAs may be lower than that of dermatologists.” However, the study ...Explore the latest in dermatology, including diagnosis and management of allergic, inflammatory, autoimmune and genetic diseases of the skin. Publication. All Publications.10 May 2023 ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA ... Acta Derm Venereol. 2016;96(2):157 ...The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your …JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Sidbury R , Davis DM , Cohen DE , et al; American Academy of Dermatology. Guidelines of care for the management of atopic dermatitis: section 3—management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71 (2):327-349. doi: 10.1016/j.jaad.2014.03.030 PubMed Google Scholar Crossref.Disclaimer: Dr Micheletti is an Images in Dermatology Editor and Dr Shinkai is Editor of JAMA Dermatology, but they were not involved in any of the decisions regarding review of the manuscript or its acceptance. Data Sharing Statement: See Supplement 2. Dec 1, 2013 · Goldsmith LA, Bolognia JL, Callen JP, et al; American Academy of Dermatology. American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations [published correction appears in J Am Acad Dermatol . 2004:51(3):348]. Key Points. Question What is the prevalence of psoriasis in adults in the US, and how has prevalence changed since 2003?. Findings In this nationally representative cross-sectional study including 12 625 participants, the prevalence of psoriasis in adults in the US was 3.0%, indicating that more than 7.5 million adults 20 years or older have psoriasis. The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology …Aug 31, 2021 · We read with great interest the article of Blauvelt et al investigating the safety and efficacy of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis (AD).1 We do agree with the author that upadacitanib have revealed a superiority over dupilumab in term of efficacy and safety. JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) The most common dermatologic treatment during a flare episode was topical corticosteroids (35% of flare episodes [178 of 513]) followed by other oral dermatologic treatments (eg, methotrexate, cyclosporine, tacrolimus; 13% [67 of 513]), and oral corticosteroids (11% [54 of 513]) . Opioids were prescribed during 21% of flare episodes …Disclaimer: Dr Barbieri is the CME/Clinical Review and Education Editor of JAMA Dermatology but was not involved in any of the decisions regarding review of the manuscript or its acceptance. References 1. Lainscak M , Pelliccia F , Rosano G , et al. Safety profile of mineralocorticoid receptor antagonists: spironolactone and eplerenone. …Dermatology | JAMA Network. Explore the latest in dermatology, including diagnosis and management of allergic, inflammatory, autoimmune and genetic diseases of the skin. JAMA Dermatology. Full Text. Atopic dermatitis (AD) is a pruritic, chronic inflammatory skin disease characterized by recurrent flares and a family history of atopy. A hallmark feature of AD is epidermal barrier dysfunction that activates type 2 immune cells, which release Th2 cytokines (IL-4, IL-13, IL-31, and IL-22) that promote inflammation, B-cell IgE class …The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology …Key Points. Question Are nutritional supplements or dietary interventions safe and effective for patients with hair loss?. Findings In this systematic review of 30 studies of nutritional interventions, the highest-quality evidence suggests the potential effectiveness of Viviscal, Nourkrin, Nutrafol, Lamdapil, Pantogar, Capsaicin and isoflavone, omega 3 and 6 with antioxidants, apple ... JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …[email protected] Hours: 8:30 AM to 4:45 PM CT Monday through Friday USA & Canada: +1 800.262.2350 Rest of World: +1 312.670.7827. Phone: 1-312-464-4444 Hours: 7:00 AM to 5:00 PM CT Monday through Friday. Instructions for Authors and Information on Submitting Manuscripts. [email protected] JAMA Network Open …Key Points. Question What is the efficacy and safety of 4 mg and 2 mg of baricitinib in combination with background topical corticosteroid (TCS) therapy in adults with moderate to severe atopic dermatitis (AD)?. Findings In this randomized clinical trial of 329 adults with moderate to severe AD, at week 16, a validated Investigator Global Assessment for …Oct 2, 2019 · Key Points. Question What is the efficacy and safety of abrocitinib monotherapy in patients with moderate-to-severe atopic dermatitis?. Findings In this randomized clinical trial of 391 patients 12 years or older with moderate-to-severe atopic dermatitis, significantly greater proportions of patients treated with abrocitinib (200 mg or 100 mg) compared with placebo achieved an Investigator ... Evidence Review A panel of national experts in pediatric dermatology, procedural/cosmetic dermatology, plastic surgery, scars, wound healing, acne, and isotretinoin was convened. A systematic PubMed review of English-language articles published from 1982 to 2017 was performed using the following search terms: isotretinoin, 13-cis-retinoic acid ... Key Points. Question What is the risk of death after a diagnosis of melanoma in situ (MIS) in the US?. Findings In this population-based cohort study of 137 872 patients with MIS, the 15-year melanoma-specific survival was 98.4%. The 15-year relative survival, meaning overall survival relative to similar individuals in the population, was 112.4%.
Chronic pruritus is a debilitating symptom that is associated with numerous dermatologic, neurologic, and systemic diseases. It is often resistant to treatment and can cause a severe reduction in quality of life. 1 Currently, to our knowledge, there is a lack of US Food and Drug Administration–approved therapies for pruritus, so treatment can be difficult and relies on …. Adriana chechik erome
Kanade Shinkai, MD, PhD, Department of Dermatology, University of Calfornia, San Francisco, 1701 Divisadero St, San Francisco, CA 94115 ( [email protected]. In this Viewpoint, JAMA Dermatology editors review the skin findings seen in association with coronavirus disease 2019 (COVID-19), how best to respond to those. Disclaimer: Dr Adamson is an Associate Editor and Web Editor of JAMA Dermatology, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance. References: 1. Chen ST , Geller AC , Tsao H . Update on the epidemiology of melanoma. Curr Dermatol Rep. 2013;2(1):24-34. doi:10.1007/s13671 ...Explore Our Publications · JAMA · JAMA Network Open · JAMA Cardiology · JAMA Dermatology · JAMA Health Forum · JAMA Internal Medicine &mid...JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) 6 Jul 2022 ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA ... Acta Derm Venereol. 2020;100(19): ...JAMA Dermatology Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 2168-6068.19 Jan 2022 ... Cardiovascular disease is a leading cause of this excess mortality and guidelines from the American Academy of Dermatology/National Psoriasis ...Dr Shields is an Assistant Section Editor of JAMA Dermatology. Dr Shinkai is Chief Editor of JAMA Dermatology. Dr Mostaghimi is an Associate Editor of JAMA Dermatology. They were not involved in any of the decisions regarding review of the manuscript or its acceptance. References 1. Sidoroff A , Halevy S , Bavinck JNB , Vaillant L , …There are many elements of the new research that show the findings are very, very preliminary. A new nutrition study published in the Journal of the American Medical Association (J...Key Points. Question What is the risk of death after a diagnosis of melanoma in situ (MIS) in the US?. Findings In this population-based cohort study of 137 872 patients with MIS, the 15-year melanoma-specific survival was 98.4%. The 15-year relative survival, meaning overall survival relative to similar individuals in the population, was 112.4%.JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) 1 Dec 2021 ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA ... Dermatology (CLEAR Derm). View Large ....